Turning Point Brands, Inc. (TPB) Form 8-K — Aug 4, 2026
Turning Point Brands reported second quarter 2026 results with total consolidated net sales increasing 22.6% to $142.9 million, driven largely by a 128% surge in Modern Oral net sales to $68.4 million. Despite the top-line growth, net income decreased 75.2% to $3.6 million and Adjusted EBITDA fell 50.0% to $15.2 million due to significant investments in sales, marketing, and distribution for the Modern Oral segment. As a result of the strong performance in its Modern Oral category, the company raised its full-year 2026 guidance for Modern Oral Net Sales to a range of $260-$270 million, up from the previous range of $210-$225 million.
Key figures
- Eps
- 0.18
- Revenue
- 142960000
- Net Income
- 3598000
- Total Debt
- 294145000
- Revenue Yoy
- 22.6%
- Cash Position
- 268307000
- Gross profit
- 93704000
- Adjusted ebitda
- 15243000
- Adjusted diluted eps
- 0.23
- Modern oral net sales
- 68400000
- Modern oral net sales growth
- 128%
Price after filing
Close on the filing date to close N calendar days later (from $76.01). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.